Drug Profile
Research programme: acne therapies - Promeditech
Alternative Names: PMT-1185Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator ProMediTech
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Acne
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Acne in South Korea (SC, Injection)
- 03 Oct 2007 Preclinical trials in Acne in South Korea (SC)